Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Cue Biopharma, Inc. | CHIEF EXECUTIVE OFFICER, Director | Common Stock | 135K | $371K | $2.76 | Aug 14, 2023 | Direct |
Cue Biopharma, Inc. | CHIEF EXECUTIVE OFFICER, Director | Stock Option (right to buy) | 400K | Mar 6, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CUE | Cue Biopharma, Inc. | Mar 6, 2024 | 1 | $0 | 4 | Mar 8, 2024 | CHIEF EXECUTIVE OFFICER, Director |
CUE | Cue Biopharma, Inc. | Aug 14, 2023 | 1 | $8.58K | 4 | Aug 16, 2023 | CHIEF EXECUTIVE OFFICER, Director |
CUE | Cue Biopharma, Inc. | Jul 21, 2023 | 1 | $0 | 4 | Jul 25, 2023 | CHIEF EXECUTIVE OFFICER, Director |
CUE | Cue Biopharma, Inc. | Feb 16, 2023 | 1 | $0 | 4 | Feb 21, 2023 | CHIEF EXECUTIVE OFFICER, Director |
CUE | Cue Biopharma, Inc. | Mar 31, 2022 | 4 | -$157K | 4 | Apr 4, 2022 | CHIEF EXECUTIVE OFFICER, Director |
CUE | Cue Biopharma, Inc. | Mar 25, 2022 | 1 | $0 | 4 | Mar 29, 2022 | CHIEF EXECUTIVE OFFICER, Director |
CUE | Cue Biopharma, Inc. | Sep 30, 2021 | 3 | -$462K | 4 | Oct 8, 2021 | CHIEF EXECUTIVE OFFICER, Director |
CUE | Cue Biopharma, Inc. | Sep 24, 2021 | 1 | $50.1K | 4 | Sep 27, 2021 | CHIEF EXECUTIVE OFFICER, Director |